A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Altor Bioscience Corporation
James and Esther King Biomedical Research Program
Information provided by (Responsible Party):
Altor Bioscience Corporation
ClinicalTrials.gov Identifier:
First received: June 19, 2012
Last updated: August 4, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)